|
AP
Wednesday, 25 October 2006
|
|
AP - Growth in the global pharmaceutical market is expected to slow next year as generic competition in the United States and pricing pressure in Europe overshadow exploding demand in developing countries, according to a new study released Tuesday. |
|
Read more...
|
|
|
AP
Tuesday, 24 October 2006
|
|
AP - A Florida man was sentenced to more than 13 years in prison Monday for his role in a conspiracy to sell millions of dollars' worth of counterfeit and illegally imported prescription drugs, including the popular cholesterol drug Lipitor. |
|
Read more...
|
|
|
Reuters
Friday, 20 October 2006
|
|
Reuters - Eli Lilly and Co. may have
improperly influenced guidelines on the treatment of a
dangerous infection called sepsis in order to sell more of an
expensive new drug, three federal researchers said on Thursday. |
|
Read more...
|
|
|
Reuters
Tuesday, 17 October 2006
|
|
Reuters - Eli Lilly & Co. said on Tuesday
it has agreed to acquire the biotechnology company Icos Corp.
for $2.1 billion to gain full rights to the erectile
dysfunction drug Cialis. |
|
Read more...
|
|
|
AP
Tuesday, 17 October 2006
|
|
AP - Eli Lilly and Co. said Tuesday it will buy joint venture partner Icos Corp. for $2.1 billion cash in a move to get full ownership of the venture's top-selling impotence treatment, Cialis. |
|
Read more...
|
|
|
Reuters
Tuesday, 17 October 2006
|
|
Reuters - Millennium Pharmaceuticals
Inc. said on Tuesday it would not raise its $515
million bid for AnorMED Inc. , opening the door for a
rival offer to end the bidding war for the Canadian drugmaker. |
|
Read more...
|
|
|
AP
Tuesday, 17 October 2006
|
|
 AP - Women's apparel maker Liz Claiborne Inc. has tapped a pharmaceuticals executive as its next CEO. The New York-based apparel maker said Monday it named William L. McComb, 43, as chief executive officer, replacing Paul R. Charron, 64, who had previously announced his plans to retire from the company.
|
|
Read more...
|
|
|
Reuters
Saturday, 14 October 2006
|
|
Reuters - Drugmaker GlaxoSmithKline Plc
has asked U.S. pharmacists to warm patients about the
unpleasant side effects that may occur with a potential over-
the-counter diet drug. |
|
Read more...
|
|
|
AP
Friday, 13 October 2006
|
|
AP - Drugmakers Johnson & Johnson and Pfizer Inc. have agreed to sell the U.S. marketing rights to the nonprescription heartburn drug Zantac to Boehringer Ingelheim Pharmaceuticals Inc. for $509.5 million. |
|
Read more...
|
|
|
BusinessWeek Online
Thursday, 12 October 2006
|
|
BusinessWeek Online - "Want a FAT Paycheck? Sign up today!" "10 bucks on the house, no obligation." "NO Prescription Drugs!" Most people recognize e-mails with such subject lines as the calling card of spam. But are they in fact illegal, or are they simply unsolicited e-mail, unwanted perhaps but not illegal? |
|
Read more...
|
|
|
AFP
Wednesday, 11 October 2006
|
|
 AFP - The US group Barr Pharmaceuticals has secured the backing of 72.67 percent of shareholder votes in Croatia's generic drug maker PLIVA, exceeding the minimum acceptance level of 50 percent plus one share, Croatian stock market authorities said.
|
|
Read more...
|
|
|
|
<< Start < Previous 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 169 - 189 of 319 |
